You are here
Articles on Surgery in Gastric Cancer
This section of the Advances in Gastrointestinal Cancer Resource Centre focuses on the latest clinically relevant findings in the surgical treatment of gastrointestinal cancers. The peer-reviewed articles available here have been independently selected, and several commented upon, by members of the Editorial Board. Many of the articles are freely available for downloading.
Focusing initially on gastric cancer, these pages will provide new content each month to help you stay abreast of recent scientific developments in this area.
Surgical resection remains the mainstay of treatment for gastric cancer in its earlier stages. Resection may be performed endoscopically if appropriate. When complete, resection offers the possibility of long-term survival, and in the absence of residual disease, the patient may need no further treatment.1
However, gastric cancer is rarely detected at an early stage, and for later stages of gastric cancer surgery must be preceded or followed by chemotherapy or chemoradiotherapy (perhaps combined with a targeted therapy).1 D2 lymph node dissection is indicated for medically fit patients, and gastrectomy may be radical or subtotal.1
Options for the surgical treatment of gastric cancer continue to develop, with key importance for patient outcomes. To stay abreast of the most recent advances and clinical trial findings in the use of surgery for the treatment of gastrointestinal cancers, please subscribe to our eAlert to ensure you are informed of all new content as it is published on this platform.
1. Cabebe EC. Gastric cancer treatment & management. Approach considerations. In Medscape: Drugs & Diseases. Available from: http://emedicine.medscape.com/article/278744-treatment. Last updated 11 Nov 2015; accessed 7 Apr 2016.
Impact of the Surveillance Interval on the Survival of Patients Who Undergo Curative Surgery for Gastric Cancer
Park CH, Park JC, Chung H, Shin SK, Lee SK, Cheong JH, et al.Ann Surg Oncol. 2016 Feb;23(2):539-45.
Improved survival in resected oesophageal and gastric adenocarcinomas over a decade: the Royal Marsden experience 2001-2010
Fontana E, Smyth EC, Cunningham D, Rao S, Watkins D, Allum WH, Thompson J, Waddell T, Peckitt C, Chau I, Starling N.Gastric Cancer. 2015 Nov 5. [Epub ahead of print]
Variations among 5 European countries for curative treatment of resectable oesophageal and gastric cancer: A survey from the EURECCA Upper GI Group (EUropean REgistration of Cancer CAre)
M. Messager, W.O. de Steur, J.W. van Sandick, J. Reynolds, M. Pera, C. Mariette, R.H. Hardwick, E. Bastiaannet, P.G. Boelens, C.J.H. van deVelde, W.H. Allum, The EURECCA Upper GI Group.
European Journal of Surgical Oncology (EJSO), In Press, Corrected Proof, Available online 30 September 2015, Available online 30 September 2015
Comprehensive geriatric assessment in patients with gastric and gastroesophageal adenocarcinoma undergoing gastrectomy
Pujara D, Mansfield P, Ajani J, Blum M, Elimova E, Chiang YJ, Das P, Badgwell B.J Surg Oncol. 2015 Oct 19.
L. Marano, K. Polom, A. Patriti, G. Roviello, G. Falco, A. Stracqualursi, R. De Luca, R. Petrioli, M. Martinotti, D. Generali, D. Marrelli, N. Di Martino, F. Roviello
European Journal of Surgical Oncology (EJSO), In Press, Corrected Proof, Available online 14 November 2015, Available online 14 November 2015